FDA

Why This Seizure Treatment Could Be the Next Big Thing

Posted: December 2, 2019 at 9:40 am

Aquestive Therapeutics Inc. (NASDAQ: AQST) shares jumped early on Monday after the firm announced the completion of its rolling submission of a New Drug Application (NDA) to the U.S. Food ...
Read Full Story »

Major Biopharma Catalysts on the December FDA Calendar

Posted: November 29, 2019 at 10:40 am

Companies in the biotech and pharmaceutical industries are subject to a sizable amount of risk with regards to their drug candidates passing clinical trials and gaining regulatory approval. But with ...
Read Full Story »

Why This Newly FDA Approved Sickle Cell Treatment Will Be Huge

Posted: November 26, 2019 at 11:02 am

Global Blood Therapeutics, Inc. (NASDAQ: GBT) shares jumped on Tuesday after the firm announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for Oxbryta (voxelotor) tablets ...
Read Full Story »

A Big Step Forward For the Treatment of ALS

Posted: November 25, 2019 at 9:44 am

Aquestive Therapeutics, Inc. (NASDAQ: AQST) shares jumped on Monday after the firm announced that its treatment of amyotrophic lateral sclerosis (ALS), Exservan, received early-action approval from the U.S. Food and ...
Read Full Story »

Why This FDA Breakthrough Is a Big Deal for Recurrent Pericarditis Patients

Posted: November 20, 2019 at 11:15 am

Kiniksa Pharmaceuticals Ltd. (NASDAQ: KNSA) shares jumped on Wednesday after the firm announced that the U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy designation for rilonacept for the treatment ...
Read Full Story »

Is This DMD Study Sunk After FDA Update?

Posted: November 12, 2019 at 11:36 am

Solid Biosciences Inc. (NASDAQ: SLDB) shares were absolutely crushed on Tuesday after the firm announced that the U.S. Food and Drug Administration (FDA) has placed its Ignite DMD Phase 1/2 ...
Read Full Story »

Is This FDA Update the Death of Lipocine?

Posted: November 11, 2019 at 11:00 am

Lipocine Inc. (NASDAQ: LPCN) shares absolutely plummeted on Monday after the firm announced that it received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) regarding ...
Read Full Story »

Meet the Newest FDA Approval in the Fight Against Non-Cardia Gastric Cancer

Posted: November 4, 2019 at 10:00 am

RedHill Biopharma Ltd. (NASDAQ: RDHL) shares jumped early on Monday after the firm announced that the U.S. Food and Drug Administration (FDA) approved Talicia for the treatment of Helicobacter pylori ...
Read Full Story »

Multiple Sclerosis Treatment Wins Big FDA Approval

Posted: October 30, 2019 at 1:05 pm

Biogen Inc. (NASDAQ: BIIB) and Alkermes PLC (NASDAQ: ALKS) announced an update from the U.S. Food and Drug Administration on Wednesday morning. The FDA approved Vumerity for the treatment of ...
Read Full Story »

It’s Not the FDA Holding Back This New Pneumonia Treatment

Posted: October 25, 2019 at 10:45 am

Melinta Therapeutics Inc. (NASDAQ: MLNT) has announced that the U.S. Food and Drug Administration (FDA) has approved Baxdela (delafloxacin) for the treatment of adult patients with community-acquired bacterial pneumonia (CABP) ...
Read Full Story »

Eton Pharma Wins Big With FDA Hypotension Treatment Approval

Posted: October 22, 2019 at 12:05 pm

Eton Pharmaceuticals Inc. (NASDAQ: ETON) shares jumped on Tuesday after the firm announced that the U.S. Food and Drug Administration (FDA) has approved Biorphen. Biorphen is the first and only ...
Read Full Story »

New Osteoarthritis Treatment Has to Wait Even Longer for FDA Approval

Posted: October 14, 2019 at 10:00 am

Flexion Therapeutics Inc. (NASDAQ: FLXN) has announced that the U.S. Food and Drug Administration (FDA) informed the company that it needs additional time to complete the review of the supplemental ...
Read Full Story »

Major Step Forward in Peanut Allergy Treatment

Posted: October 7, 2019 at 9:45 am

DBV Technologies S.A. (NASDAQ: DBVT) shares dipped early Monday after the firm announced an update from the U.S. Food and Drug Administration (FDA). Although it was a positive update for ...
Read Full Story »

America’s Unsafe Medical Products

Posted: October 4, 2019 at 12:30 pm

The U.S. Food and Drug Administration (FDA) issued seven new safety alerts in the final two weeks of September, six related to product recalls and one safety communication related to ...
Read Full Story »

Is the FDA Going Too Soft on Zantac?

Posted: October 4, 2019 at 10:10 am

The U.S. Food and Drug Administration (FDA) is coming down hard after the disclosure that Zantac and other generic ranitidine drugs could contain impurities and carcinogens. Instead of just a ...
Read Full Story »